Source: Eur Respir J, 50 (5) 1701127; 10.1183/13993003.01127-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Aarash D. Saleh, Bessie Kwok, Jeremy S. Brown, John R. Hurst. Correlates and assessment of excess cardiovascular risk in bronchiectasis. Eur Respir J, 50 (5) 1701127; 10.1183/13993003.01127-2017

Member's Comments

No comment yet.

Related content which might interest you: Determinants and assessment of excess cardiovascular risk in bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Modulation of cardiometabolic risk by pulmonary rehabilitation Source: International Congress 2019 – Effects of pulmonary rehabilitation other than improving exercise capacity Year: 2019 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Spirometry for the risk stratification of cardiovascular disease among the elderly Source: Eur Respir J 2007; 30: Suppl. 51, 311s Year: 2007 Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Chronic asthma and the risk of cardiovascular disease Source: Eur Respir Monogr 2020; 88: 82-95 Year: 2020 Presence of cardiovascular risk markers in OSAS Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007 Global cardiovascular disease risk in U.S. adults by severity and presence of COPD Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk? Source: Eur Respir J 2015; 46: 846-849 Year: 2015 Acute exacerbation in COPD and relationship between cardiovascular risk and functional profile Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018 Cardiovascular risk detection in COPD Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits Source: Eur Respir Monogr 2020; 88: 66-81 Year: 2020 Prevalence and risk factors of depression in patients with COPD Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Risk factors for mortality in patients with COPD exacerbation Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD Source: Eur Respir J 2016; 47:1365-1373 Year: 2016 Prevalence of COPD in the general population according to cardiovascular risk factors Source: Eur Respir J 2007; 30: Suppl. 51, 778s Year: 2007 Screening for the risk of malnutrition in COPD patients Source: Annual Congress 2008 - Impact of nursing interventions on the quality of care for COPD patients Year: 2008 Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Incidence and specific risk factors of falling in pulmonary rehabilitation Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention Year: 2010